Aceto Corp (ACET): Satish Srinivasan , President & COO – Rising Pharm of Aceto Corp sold 3,497 shares on Jun 6, 2016. The Insider selling transaction was reported by the company on Jun 7, 2016 to the Securities and Exchange Commission. The shares were sold at $22.69 per share for a total value of $79,341.69 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on Jun 7, 2016, Frank Debenedittis (Sr. Vice President) sold 6,810 shares at $22.63 per share price.On Jun 2, 2016, Albert L Eilender (Chairman) sold 9,881 shares at $22.21 per share price.Also, On May 27, 2016, Douglas A Roth (Sr. Vice President & CFO) sold 7,000 shares at $22.16 per share price.On Mar 14, 2016, Raymond Bartone (Senior Vice President) sold 3,000 shares at $22.40 per share price.
Shares of Aceto Corporation (ACET) ended Friday, Jun 3, 2016 session in red amid volatile trading. The shares closed down -0.46 points or -2.01% at $22.48 with 2,43,358 shares getting traded. Post opening the session at $23, the shares hit an intraday low of $22.01 and an intraday high of $23 and the price vacillated in this range throughout the day. The company has a market cap of $665 M and the number of outstanding shares has been calculated to be 2,95,85,085 shares. The 52-week high of Aceto Corporation is $32.2 and the 52-week low is $19.204.
Company has been under the radar of several Street Analysts.Aceto Corporation is Initiated by First Analysis Sec to Overweight and the brokerage firm has set the Price Target at $30. The Rating was issued on Mar 31, 2016.
Aceto Corporation (Aceto) is engaged in marketing sales and distribution of finished dosage form generic pharmaceuticals nutraceutical products pharmaceutical active ingredients and intermediates specialty performance chemicals inclusive of agricultural intermediates and agricultural protection products. The Company’s business is organized along product lines into three segments: Human Health Pharmaceutical Ingredients and Performance Chemicals. The Human Health segment includes finished dosage form generic drugs and nutraceutical products. The Pharmaceutical Ingredients segment has two product groups: Active Pharmaceutical Ingredients (APIs) and Pharmaceutical Intermediates. The Performance Chemicals segment includes specialty chemicals and agricultural protection products. The Company has operations in China Germany France the Netherlands Singapore India Hong Kong Philippines the United Kingdom and the United States.